000 | 01946 a2200601 4500 | ||
---|---|---|---|
005 | 20250517200730.0 | ||
264 | 0 | _c20180820 | |
008 | 201808s 0 0 eng d | ||
022 | _a1471-2407 | ||
024 | 7 |
_a10.1186/s12885-018-4012-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVasaikar, Suhas | |
245 | 0 | 0 |
_aOverexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target? _h[electronic resource] |
260 |
_bBMC cancer _c02 2018 |
||
300 |
_a154 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aEndothelin Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aGene Regulatory Networks |
650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptor, Endothelin B _xgenetics |
700 | 1 | _aTsipras, Giorgos | |
700 | 1 | _aLandázuri, Natalia | |
700 | 1 | _aCosta, Helena | |
700 | 1 | _aWilhelmi, Vanessa | |
700 | 1 | _aScicluna, Patrick | |
700 | 1 | _aCui, Huanhuan L | |
700 | 1 | _aMohammad, Abdul-Aleem | |
700 | 1 | _aDavoudi, Belghis | |
700 | 1 | _aShang, Mingmei | |
700 | 1 | _aAnanthaseshan, Sharan | |
700 | 1 | _aStrååt, Klas | |
700 | 1 | _aStragliotto, Giuseppe | |
700 | 1 | _aRahbar, Afsar | |
700 | 1 | _aWong, Kum Thong | |
700 | 1 | _aTegner, Jesper | |
700 | 1 | _aYaiw, Koon-Chu | |
700 | 1 | _aSöderberg-Naucler, Cecilia | |
773 | 0 |
_tBMC cancer _gvol. 18 _gno. 1 _gp. 154 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-018-4012-7 _zAvailable from publisher's website |
999 |
_c28052745 _d28052745 |